Practice-vs physician-level variation in use of active surveillance for men with low-risk prostate cancer : Implications for collaborative quality improvement. / Auffenberg, Gregory B.; Lane, Brian R.; Linsell, Susan; Cher, Michael L.; Miller, David C.In: JAMA surgery, Vol. 152, No. 10, 10.2017, p. 978-980.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Practice-vs physician-level variation in use of active surveillance for men with low-risk prostate cancer
T2 - Implications for collaborative quality improvement
AU - Auffenberg, Gregory B.
AU - Lane, Brian R.
AU - Linsell, Susan
AU - Cher, Michael L.
AU - Miller, David C.
N1 - Funding Information: Conflict of Interest Disclosures: Dr Auffenberg reported receiving grant support from the National Cancer Institute. Dr Miller reported receiving grant support from the National Cancer Institute and receiving contract support from Blue Cross Blue Shield of Michigan for serving as the director of the Michigan Urological Surgery Improvement Collaborative. No other disclosures are reported. Funding/Support: Support for Michigan Urological Surgery Improvement Collaborative is provided by Blue Cross and Blue Shield of Michigan as part of the Blue Cross and Blue Shield of Michigan Value Partnerships program. This study was also funded by grant T32-CA180984 from the National Cancer Institute (Dr Auffenberg). Role of the Funder/Sponsor: Neither Blue Cross and Blue Shield of Michigan nor the National Cancer Institute had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: Chandy Ellimoottil, MD, MS (Department of Urology, University of Michigan, Ann Arbor), provided valuable advice on an earlier version of the manuscript. Dr Ellimoottil was not compensated for his contributions. The authors acknowledge the significant contribution of the clinical champions, urologists, administrators, and data abstractors in each participating Michigan Urological Surgery Improvement Collaborative practice (details around specific participating urologists and practices can be found at http://www.musicurology.com), as well as members of the MUSIC Coordinating Center at the University of Michigan. In addition, we acknowledge the support provided by David Share, MD, MPH; Tom Leyden, MBA; Rozanne Darland, BSBA; David Bye II, MBA; and the Value Partnerships program at Blue Cross and Blue Shield of Michigan. 1. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990-2013. JAMA. 2015;314(1):80-82. 2. Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P. Uptake of active surveillance for very-low-risk prostate cancer in Sweden [published online October 20, 2016]. JAMA Oncol. 2016. doi:10.1001 /jamaoncol.2016.3600 3. Hoffman KE, Niu J, Shen Y, et al. Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med. 2014;174(9):1450-1459.
PY - 2017/10
Y1 - 2017/10
UR - http://www.scopus.com/inward/record.url?scp=85032647239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032647239&partnerID=8YFLogxK
U2 - 10.1001/jamasurg.2017.1586
DO - 10.1001/jamasurg.2017.1586
M3 - Letter
C2 - 28636713
AN - SCOPUS:85032647239
VL - 152
SP - 978
EP - 980
JO - JAMA Surgery
JF - JAMA Surgery
SN - 2168-6254
IS - 10